Molecular targets of fenofibrate in the cardiovascular-renal axis: A unifying perspective of its pleiotropic benefits.

MLA

Balakumar, Pitchai, et al. “Molecular Targets of Fenofibrate in the Cardiovascular-Renal Axis: A Unifying Perspective of Its Pleiotropic Benefits.” Pharmacological Research, vol. 144, June 2019, pp. 132–41. EBSCOhost, https://doi.org/10.1016/j.phrs.2019.03.025.

APA

Balakumar, P., Sambathkumar, R., Mahadevan, N., Muhsinah, A. B., Alsayari, A., Venkateswaramurthy, N., & Dhanaraj, S. A. (2019). Molecular targets of fenofibrate in the cardiovascular-renal axis: A unifying perspective of its pleiotropic benefits. Pharmacological Research, 144, 132–141. https://doi.org/10.1016/j.phrs.2019.03.025

Chicago

Balakumar, Pitchai, Ramanathan Sambathkumar, Nanjaian Mahadevan, Abdullatif Bin Muhsinah, Abdulrhman Alsayari, Nallasamy Venkateswaramurthy, and Sokkalingam A Dhanaraj. 2019. “Molecular Targets of Fenofibrate in the Cardiovascular-Renal Axis: A Unifying Perspective of Its Pleiotropic Benefits.” Pharmacological Research 144 (June): 132–41. doi:10.1016/j.phrs.2019.03.025.